Multicenter Comparative Study of the Activity of the Medial Prefrontal Cortex in Vulnerability to Depression
NCT ID: NCT02171923
Last Updated: 2015-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2013-05-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder
NCT00071123
fMRI Studies of Emotional Brain Circuitry in People With Major Depression
NCT00749125
Using Functional MRI Neurofeedback to Modulate Self-blame in Major Depressive Disorder
NCT05455827
Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making
NCT05111223
Self-regulation of Prefrontal Cortex During Emotional Cognitive Control
NCT04543500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remitted depressed patients
Formerly depressed patients in remission for 6 months or more
No interventions assigned to this group
healthy controls
healthy subjects with no history of mental disorders
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In clinical remission for at least 6 months (BDI-21 ≤ 10 \& Montgomery and Asberg Depression Rating Scale ≤ 7)
* Aged 20-65
Exclusion Criteria
* last episode treated by cognitive behavior therapy
* currently receiving a antipsychotic or mood-stabilizing drug
* personal history of: major depressive episode with psychotic features, other axis-I disorder (except generalized anxiety disorder), substance-related disorder (except nicotine dependence), bipolar disorder
* first-degree familial history of bipolar disorder
* cognitive impairment due to another central nervous system disease
* contra-indication to MRI
* pregnancy
* refusal to be informed of abnormal findings during the MRI
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cédric Lemogne, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
URC - HEGP, 20 rue Leblanc
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lemogne C, Delaveau P, Freton M, Guionnet S, Fossati P. Medial prefrontal cortex and the self in major depression. J Affect Disord. 2012 Jan;136(1-2):e1-e11. doi: 10.1016/j.jad.2010.11.034. Epub 2010 Dec 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P110139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.